Arkolith/Insider Trading/PNT/Form 4

Silber Allan C

Executive Chairman, DirectorPOINT Biopharma Global Inc. (PNT) · full profile →Form 4 · filed Nov 7, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 3, 2023Gift(G)500K—$038K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-115374) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML